dog-health
(5)
Vetted Bet That Pet Care Should Feel Like a Game - and Pay You Back
A Miami Beach startup closed its vet clinics, bought an Israeli AI app, and rebuilt itself around Care Coins - digital points you earn for walking, brushing and feeding your dog, then trade for real discounts. The pitch: what if Strava and Duolingo had a puppy?
Dutch
Dutch is a direct-to-consumer pet telehealth platform that connects dog and cat owners with licensed veterinarians for unlimited video consultations, personalized treatment plans, and - where state law allows - prescription medication delivered to the door. Founded in 2021 by Hims & Hers co-founder Joe Spector, Dutch runs a membership model starting around $15/month, operates in all 50 states, and has logged more than 700,000 virtual visits while building an AI-first veterinary EMR and its own prescription and pharmacy infrastructure.
Oh Norman!
Oh Norman! is a New York-based direct-to-consumer pet wellness brand co-founded by actress and animal advocate Kaley Cuoco and operator Katie Hunt (early Warby Parker, former Hinge CBO). Named after Cuoco's late rescue dog, the company makes vet-formulated, all-natural, eco-friendly dog and cat products - supplements, treats, dental and grooming items - and donates a share of every purchase to animal rescue. The brand built a community of roughly 150,000 organic followers before selling a single product, raised $5.28M across seed rounds, and launched into national retail via Chewy in 2025.
The Farmer's Dog
The Farmer's Dog is a New York-based direct-to-consumer pet health company that cooks fresh, human-grade dog food and ships it pre-portioned to subscribers' doors. Founded in 2014 by Jonathan Regev and Brett Podolsky, it builds custom meal plans around each dog's age, weight, and breed, formulated to AAFCO complete-and-balanced standards. The company crossed roughly $1.2 billion in annualized revenue in 2024 and turned profitable, becoming one of the most successful subscription brands in the U.S. pet category.
Celine Halioua
Celine Halioua is the founder and CEO of Loyal, a San Francisco biotech company developing the first FDA-approved drug for lifespan extension - starting with dogs. Born in Austin, Texas to a Moroccan mother and German father, she studied neuroscience at UT Austin and nanotechnology at Uppsala University before pursuing a DPhil at Oxford on the health economics of gene therapy. She left Oxford to join Laura Deming's Longevity Fund as Chief of Staff, then founded Loyal in 2019 at age 24. With $250M+ in total funding and the largest clinical trial ever conducted in animal health (1,300+ dogs across 70+ clinics), Loyal's lead drug LOY-002 has cleared FDA safety and efficacy hurdles - putting it on track to become the first longevity drug ever approved for any species.